Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015325
Filing Date
2024-11-12
Accepted
2024-11-12 16:23:00
Documents
83
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20240930x10q.htm   iXBRL 10-Q 2244031
2 EX-31.1 ntra-20240930xex31d1.htm EX-31.1 13842
3 EX-31.2 ntra-20240930xex31d2.htm EX-31.2 14904
4 EX-32.1 ntra-20240930xex32d1.htm EX-32.1 10388
5 EX-32.2 ntra-20240930xex32d2.htm EX-32.2 10662
  Complete submission text file 0001558370-24-015325.txt   10338242

Data Files

Seq Description Document Type Size
6 EX-101.SCH ntra-20240930.xsd EX-101.SCH 67545
7 EX-101.CAL ntra-20240930_cal.xml EX-101.CAL 65270
8 EX-101.DEF ntra-20240930_def.xml EX-101.DEF 303282
9 EX-101.LAB ntra-20240930_lab.xml EX-101.LAB 597715
10 EX-101.PRE ntra-20240930_pre.xml EX-101.PRE 467016
86 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20240930x10q_htm.xml XML 1980194
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

EIN.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 241448632
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)